1.
J Pediatr Pharmacol Ther
; 26(7): 758-761, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34588942
RESUMO
Toxic epidermal necrolysis is a rare, life-threatening skin disease with no consensus on adjunctive treatment, particularly in pediatric patients. We present the case of a 13-year-old previously healthy patient with drug-associated toxic epidermal necrolysis who experienced significantly shortened length of hospital stay and duration of symptoms compared with published literature when treated with 2 doses of etanercept 50 mg during 5 days.